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a  b  s  t  r  a  c  t
Behc¸et’s disease (BD) is a multi-systemic vascular disorder characterized by oral and genital
ulcers, cutaneous, ocular, arthritic, vascular, central nervous system and gastrointestinal
involvement. It usually affects young adults and the etiopathogenesis is unknown. A 21-
year-old girl, Caucasian, with diagnostic BD, presented with rheumatoid arthritis, genital
lesions and multiple recurrent ulcers inside the mouth, with an erythematous halo, cov-
ered  by yellowish exudates exacerbated during menstrual periods, and in situations of
stress and anxiety. The application of low power laser in ulcers was considered in order to
decrease the inﬂammatory symptoms and pain, beyond getting the healing process acceler-
ated. The proposed therapy was able to promote pain relief, increase local microcirculation
and  repair ulcerated lesions, eliminating the need for administration of systemic or topical
medications, leading to improved quality of life.
© 2014 SECOM. Published by Elsevier España, S.L.U. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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r  e  s  u  m  e  n
La enfermedad de Behc¸et (EB) es un trastorno vascular multisistémico caracterizado por
úlceras orales y genitales, cutáneas, oculares, artritis, vascular, sistema nervioso central
y  afectación gastrointestinal. Afecta a los adultos jóvenes y la etiopatogenia es descono-
cida.  Una paciente de 21 an˜os de edad, caucásica, diagnosticada de EB, artritis reumatoide,
lesiones genitales y múltiples úlceras recurrentes dentro de la boca, con un halo eritem-exudado amarillento exacerbadas durante los períodos menstruales yatoso, cubiertas por en  situaciones de estrés y ansiedad. Se considera el tratamiento con láser de baja poten-
cia  en las úlceras con el ﬁn de disminuir los síntomas inﬂamatorios y de dolor, más allá
de  lograr la aceleración del proceso de regeneración. El tratamiento propuesto fue capaz
de  proporcionar el alivio del dolor, aumentar la microcirculación local y reparar las lesiones
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ulceradas, eliminando la necesidad de administrar medicamentos sistémicos o tópicos, que
conduce a mejorar la calidad de vida.
© 2014 SECOM. Publicado por Elsevier España, S.L.U. Este es un artículo Open Access
cia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1 – The oral ulcers in the edge and back of the tongue
tests were conduced. We  had obtained the following results:bajo la licen
Introduction
Behc¸et’s disease (BD) is a chronic inﬂammatory vascular disor-
der characterized by genital and oral recurrent ulcers, ocular,
arthritic, cutaneous, blood vessels and central nervous system
involvement, described in 1937 by Hulusi Behc¸et.1–5
The etiopathogenesis of Behc¸et’s disease is unknown. It has
been postulated that immunological abnormalities, which are
possibly induced by microbial pathogens in genetically sus-
ceptible individuals, are important in its pathogenesis. Recent
ﬁndings have both supported the signiﬁcance of genetic fac-
tors and deﬁned better the nature of inﬂammation in Behc¸et’s
disease.1,2,5
Usually the diagnosis is established in young adults and
the manifestations are more  prevalent inside the mouth, fol-
lowed by genital areas.6 With the consensus on one set of
criteria created in 1990 by The International Study Group,7
and further development of clinical protocols to measure their
activity,8 instruments for standardization of research, BD has
aroused great interest in recent years. However, BD’s treat-
ment comprises several strategies, which have been shown
empirically, due to the lack of evidence-based information
area. Laboratory tests are not useful in the diagnostic BD.
This must be done from the speciﬁc criteria proposed by
the International Study Group for Behc¸et,7 which preconizes
recurrent oral ulcerations added to two ocular, cutaneous or
genital expressions or rheumatoid arthritis.1,6,9,10 The prog-
nosis for BD has a highly variable course, quite typical with
frequent relapses and remissions.9 The mortality rate is low
and when it occurs it is due to pulmonary hemorrhage, cen-
tral nervous system or intestinal perforation. In the absence of
these complications, the prognosis is generally good.1,8,9 The
application of low power laser for treatment of oral lesions
aims to reduce the painful symptoms, accelerating the heal-
ing process and decrease inﬂammation, as reported in this
case.11–13 We  reported a clinical case of a 21-year-old girl,
Caucasian, with frequent and recurrent oral ulcers inside the
mouth and genital lesions. The application of low power laser
in ulcers was considered in order to decrease the inﬂamma-
tory symptoms and pain, beyond getting the healing process
accelerated.
Case  report
A female patient, 21-year-old Caucasian, university student,
visited the Center for Study and Care of Special Patients
(CEAPE) – Universidade Paulista – UNIP – Indianapolis Cam-
pus – São Paulo – Brazil, for diagnosis and treatment of
frequent and recurrent oral ulcers. The anamnesis was done
and the patient reported that she had been suffering from
oral and genital lesions episodes that were exacerbated dur-
ing menstrual periods, and in situations of stress and anxiety.and lips.
The oral examination (Fig. 1) revealed multiple oral ulcers in
the edge and back of the tongue, lips and mucosa bilater-
ally measuring approximately 0.5–1.2 cm with erythematous
halo and covered by yellowish exudates. The biopsy was
performed and the material was sent to the pathology’s
lab: 3 fragments of tissue with different sizes and shapes,
approximately measuring 0.2 cm × 0.2 cm × 0.1 cm,  brownish
and friable. The microscopical examination of the histological
specimen revealed a mucosa fragment lined by keratinized
stratiﬁed squamous epithelia showing acanthosis areas and
hydropic degeneration. The own lamina consists of dense tis-
sue showing chronic inﬂammatory inﬁltrate. There was no
evidence of granulomatous inﬂammation and the result pre-
sented chronic inﬂammatory process. In this case, low power
diode laser using Gallium Aluminum Arsenide (GaAIAs) with
a wavelength of 790 nm,  power 30 mW,  was punctually applied
for 2 min  and 20 s, in each clinical lesion with energy den-
sity of 4 J/cm2 each point (Fig. 2a–d). On the 7th day we  had
observed total regression of the oral lesions (Fig. 3); however,
the genital lesions had increased and had appeared edema
on knees, pain and difﬁculty to walk. The patient had gone
through medical evaluation, and the gynecological examina-
tion reported multiple ulcerations of the posterior vaginal
wall with 1.5–2 cm,  with a hyperemic halo, pain on palpa-
tion and abundant leucorrhea. In occasion, vaginal cytology,
colposcopy and pathologic anatomy of the lesion and bloodnon-speciﬁc colpite chronic with acute ﬁbrin-leukocyte crust,
erosion’s foci, exocytosis and spongiosis; vaginal and urethral
culture positive for Enterococcus sp, FAN/anti-DNA negative
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Fig. 2 – (a–d) Application of low power la
Fig. 3 – On the 7th day we  had observed total regression
of the oral lesions.
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Bnd rheumatoid factor <20. Considering the stories and labo-
atory data, the physician prescribed prednisone 20 mg/day for
5 days and maintenance of 15 mg/day. Complete regression of
he lesions previously reported was noted, with disappearance
f all preexisting symptoms. Now she is under observation.
iscussion
ehc¸et’s disease (BD) is a chronic inﬂammatory vascular disor-
er characterized by genital and oral recurrent ulcers, ocular,
rthritic, cutaneous, blood vessels and central nervous system
nvolvement.1–5
The International Study Group for Behc¸et7 preconizes
ecurrent oral ulcerations added to two ocular, cutaneous or
enital expressions or rheumatoid arthritis.1,6,9,10
The patient presented with rheumatoid arthritis, genital
esions and multiple recurrent ulcers inside the mouth, with
n erythematous halo, covered by yellowish exudates exacer-
ated during menstrual periods, and in situations of stress and
nxiety being in agreement with The International Criteria for
ehc¸et’s Disease.ser (GaAlAS) in each clinical lesion.
Conclusion
The treatment of oral ulcers in BD by low laser therapy pro-
vides decreasing of the painful symptoms, stimulates the
local microcirculation, accelerates the healing process and
decreases inﬂammation, remission from ulcerative lesions, in
a short time, eliminating the need for administration of sys-
temic or topical medications, avoiding undesirable side effects
and improving the patient’s quality of life.
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